Anna-Karin E. Palm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna-Karin E. Palm has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Patrick C. Wilson
Drukier Institute for Children’s Health, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA
7 shared publications Min Huang
Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA
5 shared publications- Carole Henry
Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA
4 shared publications Nai-Ying Zheng
Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA
4 shared publicationsYao-Qing Chen
Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA
4 shared publicationsCarole Henry
Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA
3 shared publications
Latest Publications
- 9 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (573)
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans
Antibody immunodominance to conserved influenza virus epitopes is affected by both preexisting B cell memory and route of exposure.
- 9 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (573)
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans
Antibody immunodominance to conserved influenza virus epitopes is affected by both preexisting B cell memory and route of exposure.
- 1 November 2019
- Published by American Society for Microbiology in Journal of Virology
- Vol. 93 (21)
Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study
There are ongoing efforts to increase the efficacy of influenza vaccines and to promote production strategies that can rapidly respond to newly emerging viruses. It is important to understand if current alternative seasonal vaccines, such as Flublok and Flucelvax, that use alternate production strategies can induce protective influenza-specific antibodies and to evaluate what type of epitopes are targeted by distinct vaccine formulations.
- 1 November 2019
- Published by American Society for Microbiology in Journal of Virology
- Vol. 93 (21)
Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study
There are ongoing efforts to increase the efficacy of influenza vaccines and to promote production strategies that can rapidly respond to newly emerging viruses. It is important to understand if current alternative seasonal vaccines, such as Flublok and Flucelvax, that use alternate production strategies can induce protective influenza-specific antibodies and to evaluate what type of epitopes are targeted by distinct vaccine formulations.
- Open Access
- 31 July 2019
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 1787
Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination
The success of vaccines is dependent on the generation and maintenance of immunological memory. The immune system can remember previously encountered pathogens, and memory B and T cells are critical in secondary responses to infection. Studies in mice have helped to understand how different memory B cell populations are generated following antigen exposure and how affinity for the antigen is determinant to B cell fate. Additionally, such studies were fundamental in defining memory B cell niches and how B cells respond following subsequent exposure with the same antigen. On the other hand, human studies are essential to the development of better, newer vaccines but sometimes limited by the difficulty to access primary and secondary lymphoid organs. However, work using human influenza and HIV virus infection and/or immunization in particular has significantly advanced today's understanding of memory B cells. This review will focus on the generation, function, and longevity of B-cell mediated immunological memory (memory B cells and plasma cells) in response to infection and vaccination both in mice and in humans.
- 31 July 2019
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 1787
Open AccessRemembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination
The success of vaccines is dependent on the generation and maintenance of immunological memory. The immune system can remember previously encountered pathogens, and memory B and T cells are critical in secondary responses to infection. Studies in mice have helped to understand how different memory B cell populations are generated following antigen exposure and how affinity for the antigen is determinant to B cell fate. Additionally, such studies were fundamental in defining memory B cell niches and how B cells respond following subsequent exposure with the same antigen. On the other hand, human studies are essential to the development of better, newer vaccines but sometimes limited by the difficulty to access primary and secondary lymphoid organs. However, work using human influenza and HIV virus infection and/or immunization in particular has significantly advanced today's understanding of memory B cells. This review will focus on the generation, function, and longevity of B-cell mediated immunological memory (memory B cells and plasma cells) in response to infection and vaccination both in mice and in humans.
- 1 March 2019
- Published by Elsevier in Cell Host & Microbe
- Vol. 25 (3) , 357-366.e6
Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals
- 1 March 2019
- Published by Elsevier in Cell Host & Microbe
- Vol. 25 (3) , 357-366.e6
Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals
- Top Cited Papers
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies
- 1 January 2018
- Published by Elsevier in Trends in Immunology
- Vol. 39 (1) , 70-79
From Original Antigenic Sin to the Universal Influenza Virus Vaccine
- 1 January 2018
- Published by Elsevier in Trends in Immunology
- Vol. 39 (1) , 70-79
From Original Antigenic Sin to the Universal Influenza Virus Vaccine
- 13 January 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 2 (7)
Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation
In this study, we report that antigen-specific CD19+CD27+CD21lo (CD21lo) B cells are transiently induced 14 to 28 days after immunization, at the time germinal centers (GCs) peak. Although clonally related to memory B cells and plasmablasts, CD21lo cells form distinct clades within phylogenetic trees based on accumulated variable gene mutations, supporting exit from active GCs. CD21lo cells express a transcriptional program, suggesting that they are primed for plasma cell differentiation and are refractory to GC differentiation, although they do not spontaneously secrete antibody. In addition, CD21lo cells differentially express multiple cell surface markers and have elevated intracellular levels of Blimp-1 and T-bet protein compared with memory B cells. Together, these data support a model in which CD21lo cells are recent GC graduates that represent a distinct population from CD27+ classical memory cells, are refractory to GC reentry, and are predisposed to differentiate into long-lived plasma cells.
- 13 January 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 2 (7)
Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation
In this study, we report that antigen-specific CD19+CD27+CD21lo (CD21lo) B cells are transiently induced 14 to 28 days after immunization, at the time germinal centers (GCs) peak. Although clonally related to memory B cells and plasmablasts, CD21lo cells form distinct clades within phylogenetic trees based on accumulated variable gene mutations, supporting exit from active GCs. CD21lo cells express a transcriptional program, suggesting that they are primed for plasma cell differentiation and are refractory to GC differentiation, although they do not spontaneously secrete antibody. In addition, CD21lo cells differentially express multiple cell surface markers and have elevated intracellular levels of Blimp-1 and T-bet protein compared with memory B cells. Together, these data support a model in which CD21lo cells are recent GC graduates that represent a distinct population from CD27+ classical memory cells, are refractory to GC reentry, and are predisposed to differentiate into long-lived plasma cells.
- 1 November 2016
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 180, 59-65
Secretory immunoglobulin A and immunoglobulin G in horse saliva
- 1 November 2016
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 180, 59-65
Secretory immunoglobulin A and immunoglobulin G in horse saliva
- 21 July 2016
- Published by American Society of Hematology in Blood
- Vol. 128 (3) , 317-318
To B or not to B maintained?
In this issue of Blood, Bhoj et al explore the longevity of plasma cells (PCs) and humoral immunity in the absence of B cells. This is done by studying subjects experiencing B-cell aplasia after CD19-directed chimeric antigen receptor (CAR) therapy.1
- 21 July 2016
- Published by American Society of Hematology in Blood
- Vol. 128 (3) , 317-318
To B or not to B maintained?
In this issue of Blood, Bhoj et al explore the longevity of plasma cells (PCs) and humoral immunity in the absence of B cells. This is done by studying subjects experiencing B-cell aplasia after CD19-directed chimeric antigen receptor (CAR) therapy.1
- Open Access
- 9 June 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 27687
Nodal marginal zone B cells in mice: a novel subset with dormant self-reactivity
Marginal zone (MZ) B cells, representing a distinct subset of innate-like B cells, mount rapid T-independent responses to blood-borne antigens. They express low-affinity polyreactive antigen receptors that recognize both foreign and self-structures. The spleen is considered the exclusive site for murine MZ B cells. However, we have here identified B cells with a MZ B-cell phenotype in the subcapsular sinuses of mouse lymph nodes. The nodal MZ (nMZ) B cells display high levels of IgM, costimulators and TLRs, and are represented by naïve and memory cells. The frequency of nMZ B cells is about 1–6% of nodal B cells depending on mouse strain, with higher numbers in older mice and a trend of increased numbers in females. There is a significant expansion of nMZ B cells following immunization with an autoantigen, but not after likewise immunization with a control protein or with the adjuvant alone. The nMZ B cells secrete autoantibodies upon activation and can efficiently present autoantigen to cognate T cells in vitro, inducing T-cell proliferation. The existence of self-reactive MZ B cells in lymph nodes may be a source of autoantigen-presenting cells that in an unfortunate environment may activate T cells leading to autoimmunity.
- 9 June 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 27687
Open AccessNodal marginal zone B cells in mice: a novel subset with dormant self-reactivity
Marginal zone (MZ) B cells, representing a distinct subset of innate-like B cells, mount rapid T-independent responses to blood-borne antigens. They express low-affinity polyreactive antigen receptors that recognize both foreign and self-structures. The spleen is considered the exclusive site for murine MZ B cells. However, we have here identified B cells with a MZ B-cell phenotype in the subcapsular sinuses of mouse lymph nodes. The nodal MZ (nMZ) B cells display high levels of IgM, costimulators and TLRs, and are represented by naïve and memory cells. The frequency of nMZ B cells is about 1–6% of nodal B cells depending on mouse strain, with higher numbers in older mice and a trend of increased numbers in females. There is a significant expansion of nMZ B cells following immunization with an autoantigen, but not after likewise immunization with a control protein or with the adjuvant alone. The nMZ B cells secrete autoantibodies upon activation and can efficiently present autoantigen to cognate T cells in vitro, inducing T-cell proliferation. The existence of self-reactive MZ B cells in lymph nodes may be a source of autoantigen-presenting cells that in an unfortunate environment may activate T cells leading to autoimmunity.